Table 2 Association between CMI and the risk of prevalent CMM in NAFLD participants.

From: Association between cardiometabolic index and cardiometabolic multimorbidity in non-alcoholic fatty liver disease patients: evidence from a cross-sectional study

 

Model 1

OR (95% CI)

P value

Model 2

OR (95% CI)

P value

Model 3

OR (95% CI)

P value

CMI (per SD increase)

1.085 (1.008,1.166)

0.029

1.221 (1.096,1.359)

< 0.001

1.196 (1.077,1.328)

< 0.001

Quartiles of CMI

 Quartile 1

Reference

 

Reference

 

Reference

 

 Quartile 2

1.149 (0.938,1.408)

0.178

1.293 (1.032,1.621)

0.026

1.201 (0.948,1.521)

0.127

 Quartile 3

1.281 (1.044,1.571)

0.018

1.613 (1.282,2.030)

< 0.0001

1.464 (1.162,1.844)

0.001

 Quartile 4

1.547 (1.250,1.914)

< 0.0001

2.390 (1.866,3.061)

< 0.0001

2.180 (1.699,2.797)

< 0.0001

 P for trend

 

< 0.001

 

< 0.0001

 

< 0.0001

  1. Model 1: no covariates were adjusted. Model 2: Age, gender, and race were adjusted. Model 3: Adjusted for age, gender, race, PIR, BMI, smoking behavior, drinking behavior, physical activity, and lipid-lowering therapy.
  2. CMI cardiometabolic index, CMM cardiometabolic multimorbidity, NAFLD non-alcoholic fatty liver disease, PIR the poverty-to-income ratio, BMI Body Mass Index.
Back to article page